Trial · NCT03902080
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline at Week 12 in the Average Number of Micturition Episodes Per Day | Vibegron 75 Milligrams (mg) Once Daily (QD) | -2.04 | Standard Error 0.109 | Micturitions per day | |
| Change From Baseline at Week 12 in the Average Number of Micturition Episodes Per Day | Placebo | -1.30 | Standard Error 0.109 | Micturitions per day | |
| Change From Baseline at Week 12 in the Average Number of Urgency Episodes (Need to Urinate Immediately) Per Day | Vibegron 75 Milligrams (mg) Once Daily (QD) | -2.88 | Standard Error 0.164 | Urgency Episodes per Day | |
| Change From Baseline at Week 12 in the Average Number of Urgency Episodes (Need to Urinate Immediately) Per Day | Placebo | -1.93 | Standard Error 0.164 | Urgency Episodes per Day | |
| Change From Baseline at Week 12 in the Average Number of Nocturia Episodes Per Night | Vibegron 75 Milligrams (mg) Once Daily (QD) | -0.88 | Standard Error 0.054 | Nocturia episodes per night | |
| Change From Baseline at Week 12 in the Average Number of Nocturia Episodes Per Night | Placebo | -0.66 | Standard Error 0.054 | Nocturia episodes per night | |
| Change From Baseline at Week 12 in the Average Number of Urge Urinary Incontinence (UUI) Episodes Per Day for Participants With Urinary Incontinence at Baseline | Vibegron 75 Milligrams (mg) Once Daily (QD) | -2.19 | Standard Error 0.210 | UUI Episodes Per Day | |
| Change From Baseline at Week 12 in the Average Number of Urge Urinary Incontinence (UUI) Episodes Per Day for Participants With Urinary Incontinence at Baseline | Placebo | -1.39 | Standard Error 0.202 | UUI Episodes Per Day | |
| Change From Baseline at Week 12 in the International Prostate Symptom Score (IPSS) Storage Score (1-week Recall) | Vibegron 75 Milligrams (mg) Once Daily (QD) | -3.0 | Standard Error 0.13 | Scores on a scale | |
| Change From Baseline at Week 12 in the International Prostate Symptom Score (IPSS) Storage Score (1-week Recall) | Placebo | -2.2 | Standard Error 0.13 | Scores on a scale | |
| Change From Baseline at Week 12 in the Average Volume Voided Per Micturition | Vibegron 75 Milligrams (mg) Once Daily (QD) | 25.63 | Standard Error 2.328 | mL | |
| Change From Baseline at Week 12 in the Average Volume Voided Per Micturition | Placebo | 10.56 | Standard Error 2.330 | mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03902080/results